The recent introduction of PET/CT using a PSMA radioligand for imaging of PCa BCR has shown promising results due to its performance in detecting lesions, even at very low PSA levels, impacting on the therapeutic management of PCa patients [12,13,14]. Here, BCR is linked to posterior cortical atrophy.